Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glargine/Lixisenatide FRC vs Insulin Glargine in T2DM
NCT01476475Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2011
- Primary completion
- Dec 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 13
01
Overview
A Phase 2 trial of insulin glargine + lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Nov 2011; status: completed.
02
Drugs
insulin glargine + lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01476475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01476475.